Induction of epithelial-mesenchymal transition with O-glycosylated oncofetal fibronectin

FEBS Letters

Volumn 586, Issue 13, 2012, Pages 1813-1820

  Ding, Yao ^a,b   Gelfenbeyn, Kirill ^a,b   Freire De Lima, Leonardo ^a,b   Handa, Kazuko ^a,b   Hakomori, Sen Itiroh ^a,b  

^a PACIFIC NORTHWEST RESEARCH INSTITUTE   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

Author keywords

EMT; Non small cell lung cancer; O GalNAc; Oncofetal FN; TGF 1

Indexed keywords

FIBRONECTIN; MONOCLONAL ANTIBODY; N ACETYLGALACTOSAMINE; ONCOFETAL FIBRONECTIN; TRANSFORMING GROWTH FACTOR BETA1; UNCLASSIFIED DRUG;

ARTICLE; CANCER CELL; CANCER GROWTH; CANCER TISSUE; CARCINOMA CELL; CONTROLLED STUDY; EMBRYO DEVELOPMENT; EPITHELIAL MESENCHYMAL TRANSITION; FETUS (ANATOMY); FETUS CELL; HUMAN; HUMAN CELL; LUNG CARCINOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN GLYCOSYLATION;

ANIMALS; ANTIBODIES, MONOCLONAL; CARCINOMA, NON-SMALL-CELL LUNG; CELL LINE, TUMOR; EPITHELIAL-MESENCHYMAL TRANSITION; FIBRONECTINS; HUMANS; MICE; MICE, INBRED BALB C; TRANSFORMING GROWTH FACTOR BETA1;

EID: 84862501413     PISSN: 00145793     EISSN: 18733468     Source Type: Journal    
DOI: 10.1016/j.febslet.2012.05.020     Document Type: Article

References (34)

1. Hakomori, S. (1996) Tumor malignancy defined by aberrant glycosylation and sphingo(glyco)lipid metabolism. Cancer Res. 56, 5309-5318.
2. Sonnino, S. and Prinetti, A. (2010) Gangliosides as regulators of cell membrane organization and functions. Adv. Exp. Med. Biol. 688, 165-184.
3. Miura, Y., Kainuma, M., Jiang, H., Velasco, H., Vogt, P.K. and Hakomori, S. (2004) Reversion of the Jun-induced oncogenic phenotype by enhanced synthesis of sialosyllactosylceramide (GM3 ganglioside). Proc. Natl. Acad. Sci. U. S. A. 101, 16204-16209. (Pubitemid 39552823)
4. Hakomori, S. (2002) Glycosylation defining cancer malignancy: new wine in an old bottle. Proc. Natl. Acad. Sci. U. S. A. 99, 10231-10233.
5. Sonnino, S., Chigorno, V., Aureli, M., Masilamani, A.P., Valsecchi, M., Loberto, N., Prioni, S., Mauri, L. and Prinetti, A. (2011) Role of gangliosides and plasma membrane-associated sialidase in the process of cell membrane organization. Adv. Exp. Med. Biol. 705, 297-316.
6. Freire-de-Lima, L., Gelfenbeyn, K., Ding, Y., Mandel, U., Clausen, H., Handa, K. and Hakomori, S. (2011) Involvement of O-glycosylation defining oncofetal fibronectin in epithelial-mesenchymal transition process. Proc. Natl. Acad. Sci. U. S. A. 108, 17690-17695.
7. Guan, F., Schaffer, L., Handa, K. and Hakomori, S. (2010) Functional role of gangliotetraosylceramide in epithelial-to-mesenchymal transition process induced by hypoxia and by TGF-b. FASEB J. 24, 4889-4903.
8. Guan, F., Handa, K. and Hakomori, S. (2009) Specific glycosphingolipids mediate epithelial-to-mesenchymal transition of human and mouse epithelial cell lines. Proc. Natl. Acad. Sci. U. S. A. 106, 7461-7466.
9. Greenburg, G. and Hay, E.D. (1982) Epithelia suspended in collagen gels can lose polarity and express characteristics of migrating mesenchymal cells. J. Cell Biol. 95, 333-339. (Pubitemid 13197104)
10. Hay, E.D. (1995) An overview of epithelio-mesenchymal transformation. Acta Anat. (Basel) 154, 8-20.
11. Nieto, M.A. (2011) The ins and outs of the epithelial to mesenchymal transition in health and disease. Annu. Rev. Cell Dev. Biol. 27, 347-376.
12. Hanahan, D. and Weinberg, R.A. (2011) Hallmarks of cancer: the next generation. Cell 144, 646-674.
13. Thiery, J.P., Acloque, H., Huang, R.Y. and Nieto, M.A. (2009) Epithelialmesenchymal transitions in development and disease. Cell 139, 871-890.
14. Lee, J.M., Dedhar, S., Kalluri, R. and Thompson, E.W. (2006) The epithelialmesenchymal transition: new insights in signaling, development, and disease. J. Cell Biol. 172, 973-981.
15. Kalluri, R. and Neilson, E.G. (2003) Epithelial-mesenchymal transition and its implications for fibrosis. J. Clin. Invest. 112, 1776-1784. (Pubitemid 38063698)
16. Matsuura, H. and Hakomori, S. (1985) The oncofetal domain of fibronectin defined by monoclonal antibody FDC-6: its presence in fibronectins from fetal and tumor tissues and its absence in those from normal adult tissues and plasma. Proc. Natl. Acad. Sci. U. S. A. 82, 6517-6521. (Pubitemid 16230545)
17. Matsuura, H., Takio, K., Titani, K., Greene, T., Levery, S.B., Salyan, M.E.K. and Hakomori, S. (1988) The oncofetal structure of human fibronectin defined by monoclonal antibody FDC-6: Unique structural requirement for the antigenic specificity provided by a glycosylhexapeptide. J. Biol. Chem. 263, 3314-3322. (Pubitemid 18072789)
18. Matsuura, H., Greene, T. and Hakomori, S. (1989) An a- Nacetylgalactosaminylation at the threonine residue of a defined peptide sequence creates the oncofetal peptide epitope in human fibronectin. J. Biol. Chem. 264, 10472-10476. (Pubitemid 19161611)
19. Bennett, E.P., Hassan, H., Mandel, U., Hollingsworth, M.A., Akisawa, N., Ikematsu, Y., Merkx, G., Geurts van Kessel, A., Olofsson, S. and Clausen, H. (1999) Cloning and characterization of a close homologue of human UDP-Nacetyl-alpha-D-galactosamine:Polypeptide Nacetylgalactosaminyltransferase- T3, designated GalNAc-T6. Evidence for genetic but not functional redundancy. J. Biol. Chem. 274, 25362-25370.
20. Todeschini, A.R., Dos Santos, J.N., Handa, K. and Hakomori, S. (2008) Ganglioside GM2/GM3 complex affixed on silica nanospheres strongly inhibits cell motility through CD82/cMet-mediated pathway. Proc. Natl. Acad. Sci. U. S. A. 105, 1925-1930. (Pubitemid 351439441)
21. Engvall, E. and Ruoslahti, E. (1977) Binding of soluble form of fibroblast surface protein, fibronectin, to collagen. Int. J. Cancer 20, 1-5. (Pubitemid 8139735)
22. Todeschini, A.R., Dos Santos, J.N., Handa, K. and Hakomori, S. (2007) Ganglioside GM2-tetraspanin CD82 complex inhibits Met and its cross-talk with integrins, providing a basis for control of cell motility through glycosynapse. J. Biol. Chem. 282, 8123-8133. (Pubitemid 47093583)
23. Mitsuzuka, K., Handa, K., Satoh, M., Arai, Y. and Hakomori, S. (2005) A specific microdomain ("glycosynapse 3") controls phenotypic conversion and reversion of bladder cancer cells through GM3-mediated interaction of alpha3beta1 integrin with CD9. J. Biol. Chem. 280, 35545-35553. (Pubitemid 41532746)
24. Toledo, M.S., Suzuki, E., Handa, K. and Hakomori, S. (2004) Cell growth regulation through GM3-enriched microdomain (glycosynapse) in human lung embryonal fibroblast WI38 and its oncogenic transformant VA13. J. Biol. Chem. 279, 34655-34664. (Pubitemid 39318095)
25. Gill, D.J., Clausen, H. and Bard, F. (2011) Location, location, location: new insights into O-GalNAc protein glycosylation. Trends Cell Biol. 21, 149-158.
26. Bennett, E.P., Mandel, U., Clausen, H., Gerken, T.A., Fritz, T.A. and Tabak, L.A. (2011) Control of Mucin-Type O-Glycosylation - A Classification of the Polypeptide GalNAc-transferase Gene Family. Glycobiology [Epub ahead of print].
27. Varki, A., Etzler, M.E., Cummings, R.D. and Esko, J.D. (2008) Essentials of Glycobiology, 2nd edition, Cold Spring Harbor Laboratory Press, Cold Spring Harbor (NY). 115-127.
28. Steentoft, C., Vakhrushev, S.Y., Vester-Christensen, M.B., Schjoldager, K.T., Kong, Y., Bennett, E.P., Mandel, U., Wandall, H., Levery, S.B. and Clausen, H. (2011) Mining the O-glycoproteome using zinc-finger nucleaseglycoengineered SimpleCell lines. Nat. Methods 8, 977-982.
29. White, E.S. and Muro, A.F. (2011) Fibronectin splice variants: understanding their multiple roles in health and disease using engineered mouse models. IUBMB. Life 63, 538-546.
30. White, E.S., Baralle, F.E. and Muro, A.F. (2008) New insights into form and function of fibronectin splice variants. J. Pathol. 216, 1-14.
31. Pankov, R. and Yamada, K.M. (2002) Fibronectin at a glance. J. Cell Sci. 115, 3861-3863. (Pubitemid 35256486)
32. Zardi, L., Carnemolla, B., Siri, A., Petersen, T.E., Paolella, G., Sebastio, G. and Baralle, F.E. (1987) Transformed human cells produce a new fibronectin isoform by preferential alternative splicing of a previously unobserved exon. EMBO J. 6, 2337-2342.
33. Park, J.H., Katagiri, T., Chung, S., Kijima, K. and Nakamura, Y. (2011) Polypeptide N-acetylgalactosaminyltransferase 6 disrupts mammary acinar morphogenesis through O-glycosylation of fibronectin. Neoplasia 13, 320-326.
34. Barnes, J.L. and Gorin, Y. (2011) Myofibroblast differentiation during fibrosis: role of NAD(P)H oxidases. Kidney Int. 79, 944-956.